Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Diagnostic Pathology
Published in: Diagnostic Pathology 1/2013

Open Access 01-12-2013 | Research

The distinct expression patterns of claudin-10, -14, -17 and E-cadherin between adjacent non-neoplastic tissues and gastric cancer tissues

Authors: Man Gao, Wei Li, Haiming Wang, Guanjun Wang

Published in: Diagnostic Pathology | Issue 1/2013

Login to get access

Abstract

Background

Recent data indicate that the cell adhesion proteins are abnormally regulated in several human cancers and the expression of the cell adhesion proteins E-cadherin and claudin proteins is involved in the etiology and progression of cancer. It is clear that these protein represent promising targets for cancer detection, diagnosis, and therapy.

Methods

To explore the expression distinction of the cell adhesion proteins claudin-10,-14,-17 and E-cadherin in the adjacent non-neoplastic tissues and gastric cancer tissues, 50 gastric cancer tissues and 50 samples of adjacent non-neoplastic tissues adjacent to the tumors were examined for expression of claudin-10,-14,-17 and E-cadherin by streptavidin-perosidase immunohistochemical staining method.

Results

The positive expression rates of E-cadherin in gastric cancer tissues and adjacent non-neoplastic tissues were 32% and 74% respectively (P < 0.01). The positive expression rates of claudin-10 in gastric cancer tissues and adjacent non-neoplastic tissues were 24% and 72% respectively (P < 0.01). The positive expression rates of claudin-17 in gastric cancer tissues and adjacent non-neoplastic tissues were 18% and 70% (P < 0.01). In contrast, the positive expression rates of claudin-14 in gastric cancer tissues and adjacent non-neoplastic tissues were 58% and 24% respectively (P = 0.015 < 0.05) Thus in our study, the expression of E-cadherin, claudin-10, and claudin-17 was down-regulated in gastric cancer tissue while the expression of claudin-14 was up-regulated. Correlations between claudins and E-cadherin expression with lymphatic metastasis were observed.

Conclusion

Our study reveals that the expression of E-cadherin, claudin-10, and claudin-17 were down-regulated in gastric cancer tissue while the expression of claudin-14 was up-regulated and correlation between claudins and E-cadherin expression with lymphatic metastasis were observed.

Virtual slides

The virtual slide(s) for this article can be found here: http://​www.​diagnosticpathol​ogy.​diagnomx.​eu/​vs/​1475928069111326​.
Appendix
Available only for authorised users
Literature
1.
Lee M, Vasioukhin V: Cell polarity and cancer–cell and tissue polarity as a non-canonical tumor suppressor. J Cell Sci. 2008, 121: 1141-1150. 10.1242/jcs.016634.CrossRefPubMed
2.
Friedl P, Wolf K: Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer. 2003, 3: 362-374. 10.1038/nrc1075.CrossRefPubMed
3.
Johnson JP: Cell adhesion molecules of the immunoglobulin supergene family and their role in malignant transformation and progression to metastatic disease. Cancer Metastasis Rev. 1991, 10: 11-22. 10.1007/BF00046840.CrossRefPubMed
4.
Christofori G, Semb H: The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene. Trends Biochem Sci. 1999, 24: 73-76. 10.1016/S0968-0004(98)01343-7.CrossRefPubMed
5.
Berx G, Van Roy F: The E-cadherin/catenin complex: an important gatekeeper in breast cancer tumorigenesis and malignant progression. Breast Cancer Res. 2001, 3: 289-293. 10.1186/bcr309.PubMedCentralCrossRefPubMed
6.
Hirohashi S: Inactivation of the E-cadherin-mediated cell adhesion system in human cancers. Am J Pathol. 1998, 153: 333-339. 10.1016/S0002-9440(10)65575-7.PubMedCentralCrossRefPubMed
7.
Wilson AS, Power BE, Molloy PL: DNA hypomethylation and human diseases. Biochim Biophys Acta. 2007, 1775: 138-162.PubMed
8.
Szyf M, Pakneshan P, Rabbani SA: DNA methylation and breast cancer. Biochem Pharmacol. 2004, 68: 1187-1197. 10.1016/j.bcp.2004.04.030.CrossRefPubMed
9.
Comijn J, Berx G, Vermassen P, Verschueren K, van Grunsven L, Bruyneel E, Mareel M, Huylebroeck D, Van Roy F: The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol Cell. 2001, 7: 1267-1278. 10.1016/S1097-2765(01)00260-X.CrossRefPubMed
10.
Oloumi A, McPhee T, Dedhar S: Regulation of E-cadherin expression and β-catenin/Tcf transcriptional activity by the integrin-linked kinase. Biochimica et Biophysica Acta (BBA)-Molecular. Cell Res. 2004, 1691: 1-15.
11.
Provost E, Rimm DL: Controversies at the cytoplasmic face of the cadherin-based adhesion complex. Curr Opin Cell Biol. 1999, 11: 567-572. 10.1016/S0955-0674(99)00015-0.CrossRefPubMed
12.
Yap AS, Brieher WM, Gumbiner BM: Molecular and functional analysis of cadherin-based adherens junctions. Annu Rev Cell Dev Biol. 1997, 13: 119-146. 10.1146/annurev.cellbio.13.1.119.CrossRefPubMed
13.
Halbleib JM, Nelson WJ: Cadherins in development: cell adhesion, sorting, and tissue morphogenesis. Genes Dev. 2006, 20: 3199-3214. 10.1101/gad.1486806.CrossRefPubMed
14.
Niessen CM: Tight junctions/adherens junctions: basic structure and function. J Invest Dermatol. 2007, 127: 2525-2532. 10.1038/sj.jid.5700865.CrossRefPubMed
15.
Dejana E: Endothelial cell–cell junctions: happy together. Nat Rev Mol Cell Biol. 2004, 5: 261-270.CrossRefPubMed
16.
Tsukita S, Yamazaki Y, Katsuno T, Tamura A: Tight junction-based epithelial microenvironment and cell proliferation. Oncogene. 2008, 27: 6930-6938. 10.1038/onc.2008.344.CrossRefPubMed
17.
Zhang GH, Wu L, Yu GY: Tight junctions and paracellular fluid and ion transport in salivary glands. Chin J Dent Res. 2012, 16: 13-46.
18.
Morin PJ: Claudin proteins in human cancer: promising new targets for diagnosis and therapy. Cancer Res. 2005, 65: 9603-9606. 10.1158/0008-5472.CAN-05-2782.CrossRefPubMed
19.
Fanning AS, Anderson JM: PDZ domains: fundamental building blocks in the organization of protein complexes at the plasma membrane. J Clin Invest. 1999, 103: 767-772. 10.1172/JCI6509.PubMedCentralCrossRefPubMed
20.
Lee H, Seo J, Nam J-M, Char K: Nanoparticle-functionalized polymer platform for controlling metastatic cancer cell adhesion, shape, and motility. ACS Nano. 2011, 5: 5444-5456. 10.1021/nn202103z.CrossRefPubMed
21.
22.
Turksen K, Troy T-C: Barriers built on claudins. J Cell Sci. 2004, 117: 2435-2447. 10.1242/jcs.01235.CrossRefPubMed
23.
Mullin J: Epithelial barriers, compartmentation, and cancer. Sci Signal. 2004, 2004: pe2-CrossRef
24.
Van Itallie C, Rahner C, Anderson JM: Regulated expression of claudin-4 decreases paracellular conductance through a selective decrease in sodium permeability. J Clin Invest. 2001, 107: 1319-1327. 10.1172/JCI12464.PubMedCentralCrossRefPubMed
25.
Coradini D, Casarsa C, Oriana S: Epithelial cell polarity and tumorigenesis: new perspectives for cancer detection and treatment. Acta Pharmacol Sin. 2011, 32: 552-564. 10.1038/aps.2011.20.PubMedCentralCrossRefPubMed
26.
Oliveira S, Morgado-Diaz J: Claudins: multifunctional players in epithelial tight junctions and their role in cancer. Cell Mol Life Sci. 2007, 64: 17-28. 10.1007/s00018-006-6314-1.CrossRefPubMed
27.
Dhawan P, Singh AB, Deane NG, No Y, Shiou S-R, Schmidt C, Neff J, Washington MK, Beauchamp RD: Claudin-1 regulates cellular transformation and metastatic behavior in colon cancer. J Clin Invest. 2005, 115: 1765-1776. 10.1172/JCI24543.PubMedCentralCrossRefPubMed
28.
Saitou M, Furuse M, Sasaki H, Schulzke J-D, Fromm M, Takano H, Noda T, Tsukita S: Complex phenotype of mice lacking occludin, a component of tight junction strands. Mol Biol Cell. 2000, 11: 4131-4142. 10.1091/mbc.11.12.4131.PubMedCentralCrossRefPubMed
29.
Hewitt KJ, Agarwal R, Morin PJ: The claudin gene family: expression in normal and neoplastic tissues. BMC Cancer. 2006, 6: 186-10.1186/1471-2407-6-186.PubMedCentralCrossRefPubMed
30.
Tőkés A-M, Szász AM, Juhász É, Schaff Z, Harsányi L, Molnár IA, Baranyai Z, Besznyák I, Zaránd A, Salamon F: Expression of tight junction molecules in breast carcinomas analysed by array PCR and immunohistochemistry. Pathol Oncol Res. 2012, 18: 593-606. 10.1007/s12253-011-9481-9.CrossRefPubMed
31.
D’Souza T, Agarwal R, Morin PJ: Phosphorylation of claudin-3 at threonine 192 by cAMP-dependent protein kinase regulates tight junction barrier function in ovarian cancer cells. J Biol Chem. 2005, 280: 26233-26240. 10.1074/jbc.M502003200.CrossRefPubMed
32.
D’Souza T, Indig FE, Morin PJ: Phosphorylation of claudin-4 by PKCϵ regulates tight junction barrier function in ovarian cancer cells. Exp Cell Res. 2007, 313: 3364-3375. 10.1016/j.yexcr.2007.06.026.PubMedCentralCrossRefPubMed
33.
Rangel LB, Agarwal R, D’Souza T, Pizer ES, Alò PL, Lancaster WD, Gregoire L, Schwartz DR, Cho KR, Morin PJ: Tight junction proteins claudin-3 and claudin-4 are frequently overexpressed in ovarian cancer but not in ovarian cystadenomas. Clin Cancer Res. 2003, 9: 2567-2575.PubMed
34.
Long H, Crean CD, Lee W-H, Cummings OW, Gabig TG: Expression of Clostridium perfringens enterotoxin receptors claudin-3 and claudin-4 in prostate cancer epithelium. Cancer Res. 2001, 61: 7878-7881.PubMed
35.
Lin Z, Zhang X, Liu Z, Liu Q, Wang L, Lu Y, Liu Y, Wang M, Yang M, Jin X: The distinct expression patterns of claudin-2,-6, and - 11 between human gastric neoplasms and adjacent non-neoplastic tissues. Diagn Pathol. 2013, 8: 1-7. 10.1186/1746-1596-8-1.CrossRef
36.
Ohtsuki S, Yamaguchi H, Katsukura Y, Asashima T, Terasaki T: mRNA expression levels of tight junction protein genes in mouse brain capillary endothelial cells highly purified by magnetic cell sorting. J Neurochem. 2008, 104: 147-154.PubMed
37.
Tunggal JA, Helfrich I, Schmitz A, Schwarz H, Günzel D, Fromm M, Kemler R, Krieg T, Niessen CM: E-cadherin is essential for in vivo epidermal barrier function by regulating tight junctions. EMBO J. 2005, 24: 1146-1156. 10.1038/sj.emboj.7600605.PubMedCentralCrossRefPubMed
38.
Berx G, Becker KF, Höfler H, Van Roy F: Mutations of the human E-cadherin (CDH1) gene. Hum Mutat. 1998, 12: 226-237. 10.1002/(SICI)1098-1004(1998)12:4<226::AID-HUMU2>3.0.CO;2-D.CrossRefPubMed
39.
Henijink IH, Brandenburg SM, Noordhoek JA, Postma DS, Slebos D-J, Van Oosterhout AJ: Characterisation of cell adhesion in airway epithelial cell types using electric cell–substrate impedance sensing. Eur Respir J. 2010, 35: 894-903. 10.1183/09031936.00065809.CrossRef
40.
Shin K, Fogg VC, Margolis B: Tight junctions and cell polarity. Annu Rev Cell Dev Biol. 2006, 22: 207-235. 10.1146/annurev.cellbio.22.010305.104219.CrossRefPubMed
41.
Furuse M, Tsukita S: Claudins in occluding junctions of humans and flies. Trends Cell Biol. 2006, 16: 181-188. 10.1016/j.tcb.2006.02.006.CrossRefPubMed
42.
Martin TA, Jiang WG: Loss of tight junction barrier function and its role in cancer metastasis. Biochim Biophys Acta. 2009, 1788: 872-891. 10.1016/j.bbamem.2008.11.005.CrossRefPubMed
43.
Soini Y, Tommola S, Helin H, Martikainen P: Claudins 1, 3, 4 and 5 in gastric carcinoma, loss of claudin expression associates with the diffuse subtype. Virchows Arch. 2006, 448: 52-58. 10.1007/s00428-005-0011-6.CrossRefPubMed
44.
Wang T, Xuan X, Li M, Gao P, Zheng Y, Zang W, Zhao G: Astragalus saponins affect proliferation, invasion and apoptosis of gastric cancer BGC-823 cells. Diagn Pathol. 2013, 8: 179-10.1186/1746-1596-8-179.PubMedCentralCrossRefPubMed
45.
Zhang G, Qu Y, Dang S, Yang Q, Shi B, Hou P: Variable copy number of mitochondrial DNA (mtDNA) predicts worse prognosis in advanced gastric cancer patients. Diagn Pathol. 2013, 8: 173-10.1186/1746-1596-8-173.PubMedCentralCrossRefPubMed
46.
Feng CW, Wang LD, Jiao LH, Liu B, Zheng S, Xie XJ: Expression of p53, inducible nitric oxide synthase and vascular endothelial growth factor in gastric precancerous and cancerous lesions: correlation with clinical features. BMC Cancer. 2002, 2: 8-10.1186/1471-2407-2-8.PubMedCentralCrossRefPubMed
47.
Guan Z, Zhang J, Song S, Dai D: Promoter methylation and expression of TIMP3 gene in gastric cancer. Diagn Pathol. 2013, 8: 110-10.1186/1746-1596-8-110.PubMedCentralCrossRefPubMed
48.
Shang X, Lin X, Alvarez E, Manorek G, Howell SB: Tight junction proteins claudin-3 and claudin-4 control tumor growth and metastases. Neoplasia. 2012, 14: 974-PubMedCentralCrossRefPubMed
Metadata
Title
The distinct expression patterns of claudin-10, -14, -17 and E-cadherin between adjacent non-neoplastic tissues and gastric cancer tissues
Authors
Man Gao
Wei Li
Haiming Wang
Guanjun Wang
Publication date
01-12-2013
Publisher
BioMed Central
Published in
Diagnostic Pathology / Issue 1/2013
Electronic ISSN: 1746-1596
DOI
https://doi.org/10.1186/1746-1596-8-205

Other articles of this Issue 1/2013

Diagnostic Pathology 1/2013 Go to the issue

Research

Immunohistochemical detection of mutations in the epidermal growth factor receptor gene in lung adenocarcinomas using mutation-specific antibodies

Research

A comparative proteomic study identified calreticulin and prohibitin up-regulated in adrenocortical carcinomas

Research

Impaired binding of standard initiation factors eIF3b, eIF4G and eIF4B to domain V of the live-attenuated coxsackievirus B3 Sabin3-like IRES - alternatives for 5′UTR-related cardiovirulence mechanisms

Research

The association between chemosensitivity and Pgp, GST-π and Topo II expression in gastric cancer

Research

Reliability of rapid diagnostic test for diagnosing peripheral and placental malaria in an area of unstable malaria transmission in Eastern Sudan

Research

Upregulation of microRNA-224 is associated with aggressive progression and poor prognosis in human cervical cancer